Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Management of anemia in patients with cancer.

Steensma DP.

Curr Oncol Rep. 2004 Jul;6(4):297-304. Review.

PMID:
15161584
2.
3.

Clinical benefits and risks associated with epoetin and darbepoetin in patients with chemotherapy-induced anemia: a systematic review of the literature.

Ross SD, Allen IE, Henry DH, Seaman C, Sercus B, Goodnough LT.

Clin Ther. 2006 Jun;28(6):801-31. Review. Erratum in: Clin Ther. 2007 May;29(5):985-986. Clin Ther. 2007 May;29(5):985-6.

PMID:
16860166
4.

EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update.

Bokemeyer C, Aapro MS, Courdi A, Foubert J, Link H, Osterborg A, Repetto L, Soubeyran P; European Organisation for Research and Treatment of Cancer (EORTC) Taskforce for the Elderly.

Eur J Cancer. 2007 Jan;43(2):258-70. Epub 2006 Dec 19. Review.

PMID:
17182241
5.

Darbepoetin for the anaemia of chronic kidney disease.

Palmer SC, Saglimbene V, Craig JC, Navaneethan SD, Strippoli GF.

Cochrane Database Syst Rev. 2014 Mar 31;(3):CD009297. doi: 10.1002/14651858.CD009297.pub2. Review.

PMID:
24683046
6.

Epoetin alfa therapy increases hemoglobin levels and improves quality of life in patients with cancer-related anemia who are not receiving chemotherapy and patients with anemia who are receiving chemotherapy.

Quirt I, Robeson C, Lau CY, Kovacs M, Burdette-Radoux S, Dolan S, Tang SC, McKenzie M, Couture F; Canadian Eprex Oncology Study Group.

J Clin Oncol. 2001 Nov 1;19(21):4126-34.

PMID:
11689580
7.

Speed of haemoglobin response in patients with cancer: a review of the erythropoietic proteins.

Oberhoff C.

Support Care Cancer. 2007 Jun;15(6):603-611. doi: 10.1007/s00520-006-0191-x. Epub 2007 Feb 3. Review.

PMID:
17277926
8.

Effectiveness of darbepoetin alfa versus epoetin alfa for the treatment of chemotherapy induced anemia in patients with gynecologic malignancies.

Case AS, Rocconi RP, Kilgore LC, Barnes MN.

Gynecol Oncol. 2006 Jun;101(3):499-502. Epub 2006 Jan 10.

PMID:
16406064
9.

Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis.

Palmer SC, Saglimbene V, Mavridis D, Salanti G, Craig JC, Tonelli M, Wiebe N, Strippoli GF.

Cochrane Database Syst Rev. 2014 Dec 8;(12):CD010590. doi: 10.1002/14651858.CD010590.pub2. Review.

PMID:
25486075
10.

New oversight put in place for physicians giving anemia drugs to patients with cancer.

Mitka M.

JAMA. 2010 Apr 14;303(14):1355-6. doi: 10.1001/jama.2010.359. No abstract available.

PMID:
20388885
11.

Use of erythropoietin-stimulating agents in breast cancer patients: a risk review.

Crouch Z, DeSantis ER.

Am J Health Syst Pharm. 2009 Jul 1;66(13):1180-5. doi: 10.2146/ajhp080214. Review.

PMID:
19535656
12.

A multicenter retrospective cohort study of practice patterns and clinical outcomes of the use of darbepoetin alfa and epoetin alfa for chemotherapy-induced anemia.

Schwartzberg L, Shiffman R, Tomita D, Stolshek B, Rossi G, Adamson R.

Clin Ther. 2003 Nov;25(11):2781-96.

PMID:
14693304
13.

Antianemic effect of once weekly regimen of epoetin alfa 40,000 units in anemic cancer patients receiving chemotherapy.

Voravud N, Sriuranpong V, Suwanrusme H.

J Med Assoc Thai. 2007 Jun;90(6):1082-8.

PMID:
17624200
14.

Erythropoietin or Darbepoetin for patients with cancer--meta-analysis based on individual patient data.

Bohlius J, Schmidlin K, Brillant C, Schwarzer G, Trelle S, Seidenfeld J, Zwahlen M, Clarke MJ, Weingart O, Kluge S, Piper M, Napoli M, Rades D, Steensma D, Djulbegovic B, Fey MF, Ray-Coquard I, Moebus V, Thomas G, Untch M, Schumacher M, Egger M, Engert A.

Cochrane Database Syst Rev. 2009 Jul 8;(3):CD007303. doi: 10.1002/14651858.CD007303.pub2. Review.

15.

Epoetin alfa versus darbepoetin alfa in chemotherapy-related anemia.

Cersosimo RJ, Jacobson DR.

Ann Pharmacother. 2006 Jan;40(1):58-65; quiz 169-70. Epub 2005 Dec 6. Review.

PMID:
16332942
16.

Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update.

Rizzo JD, Somerfield MR, Hagerty KL, Seidenfeld J, Bohlius J, Bennett CL, Cella DF, Djulbegovic B, Goode MJ, Jakubowski AA, Rarick MU, Regan DH, Lichtin AE; American Society of Clinical Oncology; American Society of Hematology.

J Clin Oncol. 2008 Jan 1;26(1):132-49. Epub 2007 Oct 22. Erratum in: J Clin Oncol. 2008 Mar 1;26(7):1192.

PMID:
17954713
17.

Use of erythropoiesis-stimulating agents among chemotherapy patients with hemoglobin exceeding 12 grams per deciliter.

Nordstrom BL, Luo W, Fraeman K, Whyte JL, Nordyke RJ.

J Manag Care Pharm. 2008 Nov-Dec;14(9):858-69.

18.

Overview of cancer-related anemia: focus on the potential role of darbepoetin alfa.

Valley AW.

Pharmacotherapy. 2002 Sep;22(9 Pt 2):150S-159S. Review.

PMID:
12222585
19.

Epoetins and [symbol: see text] darbepoetin alfa in malignant disease.

[No authors listed]

Drug Ther Bull. 2004 Mar;42(3):21-3. Review.

PMID:
15038080
20.

Supplemental Content

Support Center